Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-060585

Interim CFO/CAO/VP of Finance sold 910 shares at $4.78 ($4,345)

  • Interim CFO/CAO/VP of Finance acquired 3,476 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Donegan Michael C · Interim CFO/CAO/VP of Finance

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-06 Exercise or conversion : show line 1 in the form +2,300 4,288 D
2022-12-06 Exercise or conversion : show line 2 in the form +380 4,668 D
2022-12-06 Exercise or conversion : show line 3 in the form +534 5,202 D
2022-12-06 Exercise or conversion : show line 4 in the form +262 5,464 D
2022-12-06 Sale : show line 5 in the form −910 $4.78 $4,345 4,554 D
Open-market sales · 910 sh · avg $4.78 · $4,345

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2022-12-06 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,300 0 D
2022-12-06 Exercise or conversion : show line 7 in the form Restricted Stock Units −380 380 D
2022-12-06 Exercise or conversion : show line 8 in the form Restricted Stock Units −534 1,066 D
2022-12-06 Exercise or conversion : show line 9 in the form Restricted Stock Units −262 519 D
Loading xslF345X03/doc4.xml…